Nuclear Medicine News and Research

RSS

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.

White House honors PET researcher with National Science Award

Joanna Fowler, Ph.D., a major contributor to brain research and a pioneer in molecular imaging, is being recognized by the White House with the National Medal of Science-the highest award for lifetime achievement in science. Eight other researchers will join Fowler to receive the award at a White House ceremony on October 7.

8 Oct 2009

MHA announces endorsement relationship between AHR, VISTA Staffing Solutions and On Assignment

The Maine Hospital Association (MHA) has announced an exclusive endorsement relationship between their wholly owned entity, Associated Health Resources, Inc. (AHR), VISTA Staffing Solutions, Inc., and On Assignment, Inc.

5 Oct 2009

SNM's joint session with CMOD on molecular imaging biomarkers in clinical research

SNM is collaborating with the International Partnership for Critical Markers of Disease (CMOD) during CMOD's 7th Annual Biomarkers and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and Conference Center, Bethesda, Md., Oct. 19th, 2009.

3 Oct 2009

New molecular imaging technique raises hope for common malignant female tumor

A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. This research was presented in a study published in the October issue of The Journal of Nuclear Medicine.

1 Oct 2009

SNM calls on Congress to support the CARE Bill

SNM is calling on Congress to support the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act (CARE bill), which would ensure that states set minimum education and credentialing standards for nuclear medicine technologists. The bill (H.R. 3652) was introduced Sept. 28 in the U.S. House of Representatives by Rep. John Barrow (D-Ga.).

30 Sep 2009

Increment in 2010 PET reimbursement may increase the demand for Cardiac PET imaging

Positron Corporation, a molecular imaging solutions company focused on Nuclear Cardiology, predicts a significant rise in demand for Cardiac PET in 2010 with a proposed cut in SPECT reimbursement of 46% and an increase in PET reimbursement of 22%, issued by the Centers for Medicare & Medicaid Services (CMS).

28 Sep 2009

Senior chemist receives nation's highest award for achievement in science

Joanna Fowler, a senior chemist and Director of the Radiotracer Chemistry, Instrumentation and Biological Imaging Program at the U.S. Department of Energy's Brookhaven National Laboratory, will be awarded the National Medal of Science at a White House ceremony on October 7. She is one of nine researchers named by President Barack Obama to receive the nation's highest award for lifetime achievement in science.

25 Sep 2009

Perot Systems to provide Revenue Cycle services to the West Georgia Health System

West Georgia Health System and Perot Systems today announced that Perot Systems will provide Revenue Cycle services to the LaGrange, Georgia-based hospital organization. The agreement will enable WGHS to utilize Perot Systems' revenue cycle technology and its proven best practices for revenue cycle improvements.

25 Sep 2009

Pakistan cardiology institute purchases Positron's Pulse compact digital cardiac camera

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announces the sale of a Pulse CDCC camera to CPE Institute Of Cardiology in Multan, Pakistan.

25 Sep 2009

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend MedAxiom’s Fall Conference in Dana Point, California September 23rd, 2009 to promote their cardiac optimized PET scanner, the Attrius™ (www.medaxiom.com).

19 Sep 2009

Comprehensive CT scan gives better indication of significant coronary artery disease

A team of researchers led by Massachusetts General Hospital (MGH) radiologists has developed a computed-tomography-based protocol that identifies both narrowing of coronary arteries and areas of myocardial ischemia - restricted blood flow to heart muscle tissue - giving a better indication of clinically significant coronary artery disease.

16 Sep 2009

PET scanning made as publicly insured health service

Positron Corporation today announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.

15 Sep 2009

Zevalin radioimmunotherapy drug approved for treating non-Hodgkin's lymphoma

SNM applauds the U.S. Food and Drug Administration's (FDA) recent decision to approve the radioimmunotherapy (RIT) drug, Zevalin, as a front-line treatment of non-Hodgkin's lymphoma (NHL).

11 Sep 2009

American Asthma Foundation awards $750,000 for asthma research

Dr. Serpil Erzurum, one of the nation's leading experts in asthma, has been awarded $750,000 by the American Asthma Foundation (AAF). Dr. Erzurum will collaborate with experts in nuclear medicine and physics to develop an innovative way for clinicians to observe changes in the lungs of patients during an asthma attack.

9 Sep 2009

SNM survey evaluates the impact of the worldwide medical isotope shortage

SNM recently conducted a survey of nuclear pharmacies-pharmacies that supply the critical radioisotope Technetium-99m, which is used in more than 16 million nuclear medicine tests each year in the United States-to assess, anecdotally, the impact of the worldwide medical isotope shortage. According to the survey, 60 percent of radiopharmacies have been impacted by the most recent shortage. Technetium-99m is a product of Molybdenum-99, which has been in short supply recently.

9 Sep 2009

Proposed Idaho nuclear plant to tackle critical shortage of lifesaving medical isotopes

Alternate Energy Holdings, Inc. (PINKSHEETS: AEHI) -- A critical worldwide shortage of nuclear isotopes has forced doctors to forgo lifesaving tests and increased testing cost -- underscoring the need for more nuclear reactors, according to AEHI, which is proposing to build a nuclear plant in Idaho.

9 Sep 2009

First-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.

3 Sep 2009

New findings on molecular imaging and prostate cancer

A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed.

2 Sep 2009

Inadequate government funding increases British Columbians' healthcare cost burden

British Columbia families will bear the brunt of the provincial government's failure to adequately fund health care, Health Sciences Association of BC president Reid Johnson said in response to the provincial government's budget introduced today.

2 Sep 2009

Daxor's signed trial agreement with Pacific Cardiology to provide the BVA-100 instrument

Daxor Corporation, a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Pacific Cardiology, LLC of Honolulu, Hawaii. This will provide Pacific Cardiology with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume.

1 Sep 2009

Nuclear Medicine News and Research

Further Reading

White House honors PET researcher with National Science Award

MHA announces endorsement relationship between AHR, VISTA Staffing Solutions and On Assignment

SNM's joint session with CMOD on molecular imaging biomarkers in clinical research

New molecular imaging technique raises hope for common malignant female tumor

SNM calls on Congress to support the CARE Bill

Increment in 2010 PET reimbursement may increase the demand for Cardiac PET imaging

Senior chemist receives nation's highest award for achievement in science

Perot Systems to provide Revenue Cycle services to the West Georgia Health System

Pakistan cardiology institute purchases Positron's Pulse compact digital cardiac camera

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Comprehensive CT scan gives better indication of significant coronary artery disease

PET scanning made as publicly insured health service

Zevalin radioimmunotherapy drug approved for treating non-Hodgkin's lymphoma

American Asthma Foundation awards $750,000 for asthma research

SNM survey evaluates the impact of the worldwide medical isotope shortage

Proposed Idaho nuclear plant to tackle critical shortage of lifesaving medical isotopes

First-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

New findings on molecular imaging and prostate cancer

Inadequate government funding increases British Columbians' healthcare cost burden

Daxor's signed trial agreement with Pacific Cardiology to provide the BVA-100 instrument

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News